BCL2 and small cell lung carcinoma: In SCLC cell lines, Bcl-2 family members have been described as important factors in chemotherapeutic drug resistance and therefore downregulation of Bcl-2 family members with an NSAID can be an interesting modality to circumvent drug resistance (Sartorius and Krammer, 2002).